Rituximab Maintenance after Autologous Stem Cell Transplantation Prolongs Survival in Younger Patients with Mantle Cell Lymphoma: Final Results of the Randomized Phase 3 LyMa Trial of the Lysa/Goelams Group

Affiliation auteurs!!!! Error affiliation !!!!
TitreRituximab Maintenance after Autologous Stem Cell Transplantation Prolongs Survival in Younger Patients with Mantle Cell Lymphoma: Final Results of the Randomized Phase 3 LyMa Trial of the Lysa/Goelams Group
Type de publicationJournal Article
Year of Publication2016
AuteursLe Gouill S, Thieblemont C, Oberic L, Moreau A, Bouabdallah K, Gyan E, Damaj G, Ribrag V, Feugier P, Casasnovas O, Zerazhi H, Haioun C, Tilly H, Tournilhac O, Maisonneuve H, Solal-Celigny P, Fornecker LMathieu, Van den Neste EW, Canioni D, Salles G, Lamy T, Bene M-C, Gressin R, Hermine O
JournalBLOOD
Volume128
Date PublishedDEC 2
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood.V128.22.145.145